HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Andrea Camerini Selected Research
Andrea Camerini Research Topics
Disease
17
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2012
12
Neoplasms (Cancer)
01/2021 - 03/2003
8
Breast Neoplasms (Breast Cancer)
02/2016 - 10/2004
6
Disease Progression
06/2018 - 08/2009
6
Renal Cell Carcinoma (Grawitz Tumor)
11/2017 - 03/2007
5
Cardiotoxicity
01/2022 - 11/2006
3
Neoplasm Metastasis (Metastasis)
01/2022 - 03/2011
3
Brain Neoplasms (Brain Tumor)
01/2021 - 03/2011
3
Lung Neoplasms (Lung Cancer)
11/2020 - 01/2017
2
Heart Failure
01/2022 - 12/2009
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2017 - 01/2015
2
Heart Diseases (Heart Disease)
12/2009 - 11/2006
1
Sudden Death
01/2022
1
Human Influenza (Influenza)
01/2021
1
Pericardial Effusion
01/2020
1
Hyponatremia
01/2019
1
Inappropriate ADH Syndrome (SIADH)
01/2019
1
Bone Diseases (Bone Disease)
06/2018
1
Neutropenia
04/2014
1
Thrombocytopenia (Thrombopenia)
04/2014
1
Diarrhea
04/2014
1
Lymphopenia (Lymphocytopenia)
04/2014
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2013
1
Adenocarcinoma
11/2013
1
Xeroderma Pigmentosum (Kaposi's Disease)
10/2012
1
Hepatocellular Carcinoma (Hepatoma)
12/2009
1
Brain Diseases (Brain Disorder)
12/2009
1
Ascites
12/2009
1
Testicular Diseases
03/2007
Drug/Important Bio-Agent (IBA)
6
pembrolizumab
IBA
01/2022 - 12/2019
5
Vinorelbine (Navelbine)
FDA Link
Generic
01/2019 - 05/2015
4
Anthracyclines
IBA
01/2022 - 06/2009
4
Dystroglycans (Dystroglycan)
IBA
09/2010 - 03/2003
3
Bevacizumab (Avastin)
FDA Link
04/2017 - 12/2014
3
Tyrosine Kinase Inhibitors
IBA
02/2017 - 10/2004
2
Platinum
IBA
01/2022 - 11/2018
2
Ligands
IBA
01/2021 - 11/2020
2
Immune Checkpoint Inhibitors
IBA
01/2021 - 01/2020
2
Hormones (Hormone)
IBA
01/2019 - 08/2009
2
Etoposide (VP 16)
FDA Link
Generic
04/2017 - 01/2015
2
Cisplatin (Platino)
FDA Link
Generic
04/2017 - 01/2015
2
Sunitinib (Sutent)
FDA Link
06/2014 - 04/2014
2
Carboplatin (JM8)
FDA Link
Generic
12/2012 - 10/2012
2
Pemetrexed (MTA)
FDA Link
12/2012 - 10/2012
1
Natriuretic Peptides
IBA
01/2022
1
sacubitril and valsartan sodium hydrate drug combination
IBA
01/2022
1
Angiotensin II
IBA
01/2022
1
Influenza Vaccines (Influenza Vaccine)
FDA Link
01/2021
1
Steroids
IBA
01/2021
1
Pharmaceutical Preparations
IBA
11/2020
1
B7-H1 Antigen
IBA
11/2020
1
Trastuzumab (Herceptin)
FDA Link
10/2019
1
Diuretics
IBA
01/2019
1
Sodium
IBA
01/2019
1
Vasopressins (Vasopressin)
IBA
01/2019
1
Tolvaptan
FDA Link
01/2019
1
Biomarkers (Surrogate Marker)
IBA
11/2018
1
Gemcitabine
FDA Link
11/2018
1
Cytidine Deaminase
IBA
11/2018
1
Morphine (MS Contin)
FDA Link
Generic
04/2018
1
Antineoplastic Agents (Antineoplastics)
IBA
11/2017
1
Cytostatic Agents
IBA
05/2015
1
Paclitaxel (Taxol)
FDA Link
Generic
12/2014
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
12/2014
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2014
1
Thrombospondin 1
IBA
12/2014
1
Interleukin-8 (Interleukin 8)
IBA
12/2014
1
Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)
IBA
10/2012
1
Thymidylate Synthase
IBA
10/2012
1
gamma-Glutamyl Hydrolase (Carboxypeptidase G2)
IBA
10/2012
1
Reduced Folate Carrier Protein
IBA
10/2012
1
Docetaxel (Taxotere)
FDA Link
04/2011
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
03/2011
1
Messenger RNA (mRNA)
IBA
03/2011
1
8-Hydroxy-2'-Deoxyguanosine
IBA
09/2010
1
Bilirubin
IBA
12/2009
1
Sorafenib (BAY 43-9006)
FDA Link
12/2009
1
Albumins
IBA
12/2009
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
12/2009
1
Biological Products
IBA
10/2009
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
10/2009
1
Phenobarbital (Luminal)
FDA Link
10/2009
1
LDL Cholesterol
IBA
08/2009
1
Estrogens (Estrogen)
FDA Link
08/2009
1
Cholesterol
IBA
08/2009
1
Fulvestrant (Faslodex)
FDA Link
08/2009
1
Superoxide Dismutase
IBA
06/2009
1
Cyclin E
IBA
06/2009
1
Epirubicin (Ellence)
FDA Link
Generic
06/2009
1
Aerosols
IBA
03/2007
1
Interleukin-2 (IL2)
IBA
03/2007
Therapy/Procedure
9
Drug Therapy (Chemotherapy)
01/2022 - 06/2009
7
Therapeutics
01/2021 - 06/2009
5
Immunotherapy
01/2021 - 03/2007
1
Defibrillators (Defibrillator)
01/2022
1
Time-to-Treatment
11/2020
1
Radiotherapy
11/2020
1
Combination Drug Therapy (Combination Chemotherapy)
01/2017
1
Metronomic Administration
05/2015
1
Drug Tapering
04/2014